Drug Shortage Report for TEVA-TOLTERODINE LA

Last updated on 2020-12-17 History
Report ID 129050
Drug Identification Number 02412209
Brand name TEVA-TOLTERODINE LA
Common or Proper name TOLTERODINE 4MG ER CAP
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) TOLTERODINE TARTRATE
Strength(s) 4MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 30
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-25
Estimated end date 2021-01-31
Actual end date 2020-12-16
Shortage status Resolved
Updated date 2020-12-17
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-12-17 French Compare
v3 2020-12-17 English Compare
v2 2020-11-27 French Compare
v1 2020-11-27 English Compare